Altogether, these findings suggest that HDAC1 and HDAC2 activities are critical to modulate the TGF-β signaling pathway and the generation of blood cells through EHT, and that TGF-β activation in HE cells might therefore be beneficial for producing blood cells for regenerative therapies. The gene discussed is HDAC2; the disease is hereditary elliptocytosis.